P27Kip1 inhibits systemic autoimmunity through the control of Treg cell activity and differentiation

Arthritis and Rheumatism

Volumn 65, Issue 2, 2013, Pages 343-354

  Iglesias, Marcos ^a   Postigo, Jorge ^a   Santiuste, Inés ^a   González, Jovanna ^a   Buelta, Luis ^a   Tamayo, Esther ^a   Merino, Jesús ^a   Merino, Ramón ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CLONAL ANERGY; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84873876503     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37778     Document Type: Article

References (41)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M,. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
2. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000; 106: R75-81.
3. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-1.
4. Fontenot JD, Gavin MA, Rudensky AY,. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330-6.
5. Hori S, Nomura T, Sakaguchi S,. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-61.
6. Khattri R, Cox T, Yasayko SA, Ramsdell F,. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4: 337-42.
7. Kingsley CI, Karim M, Bushell AR, Wood KJ,. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080-6.
8. Zhou G, Levitsky HI,. Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance. J Immunol 2007; 178: 2155-62.
9. Curiel TJ,. Regulatory T cells and treatment of cancer. Curr Opin Immunol 2008; 20: 241-6.
10. Wohlfert E, Belkaid Y,. Role of endogenous and induced regulatory T cells during infections. J Clin Immunol 2008; 28: 707-15.
11. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-86.
12. Li MO, Flavell RA,. TGF-β: a master of all T cell trades. Cell 2008; 134: 392-404.
13. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W,. A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 2008; 9: 632-40.
14. Ouyang W, Beckett O, Ma Q, Li MO,. Transforming growth factor-β signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 2010; 32: 642-53.
15. + T cell-dependent inhibition of autoimmunity in transgenic mice overexpressing human Bcl-2 in T lymphocytes. J Immunol 2007; 178: 2778-86.
16. Sharabi A, Lapter S, Mozes E,. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide. J Autoimmun 2010; 34: 87-95.
17. Linette GP, Li Y, Roth K, Korsmeyer SJ,. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci U S A 1996; 93: 9545-52.
18. Kip1, pRB relative p130, and altered E2F regulation. Mol Cell Biol 2000; 20: 4745-53.
19. Brady HJ, Gil-Gomez G, Kirberg J, Berns AJ,. Bax α perturbs T cell development and affects cell cycle entry of T cells. EMBO J 1996; 15: 6991-7001.
20. Boussiotis VA, Freeman GJ, Taylor PA, Berezovskaya A, Grass I, Blazar BR, et al. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat Med 2000; 6: 290-7.
21. Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat Immunol 2006; 7: 1157-65.
22. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ,. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67: 879-88.
23. Gonzalez J, Orlofsky A, Prystowsky MB,. A1 is a growth-permissive antiapoptotic factor mediating postactivation survival in T cells. Blood 2003; 101: 2679-85.
24. Postigo J, Genre F, Iglesias M, Fernandez-Rey M, Buelta L, Rodriguez-Rey JC, et al. Exacerbation of type II collagen-induced arthritis in apolipoprotein E-deficient mice in association with the expansion of Th1 and Th17 cells. Arthritis Rheum 2011; 63: 971-80.
25. Santiuste I, Buelta L, Iglesias M, Genre F, Mazorra F, Izui S, et al. B-cell overexpression of Bcl-2 cooperates with p21 deficiency for the induction of autoimmunity and lymphomas. J Autoimmun 2010; 35: 316-24.
26. Griffiths MM, Cremer MA, Harper DS, McCall S, Cannon GW,. Immunogenetics of collagen-induced arthritis in rats: both MHC and non-MHC gene products determine the epitope specificity of immune response to bovine and chick type II collagens. J Immunol 1992; 149: 309-16.
27. 1-bcl-2 transgenic mice. J Immunol 2004; 172: 7177-85.
28. Vogler M,. BCL2A1: the underdog in the BCL2 family. Cell Death Differ 2012; 19: 67-74.
29. Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F,. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 2004; 430: 226-31.
30. Haque R, Lei F, Xiong X, Wu Y, Song J,. FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development. Arthritis Res Ther 2010; 12: R66.
31. + regulatory T cells. J Immunol 2012; 188: 976-80.
32. + T regulatory cells. J Immunol 2010; 184: 3433-41.
33. Kip1-deficient mice. Cell 1996; 85: 733-44.
34. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996; 85: 707-20.
35. Wang Y, Hu Q, Madri JA, Rollins SA, Chodera A, Matis LA,. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sci U S A 1996; 93: 8563-68.
36. Clynes R, Dumitru C, Ravetch JV,. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998; 279: 1052-4.
37. Baudino L, Fossati-Jimack L, Chevalley C, Martinez-Soria E, Shulman MJ, Izui S,. IgM and IgA anti-erythrocyte autoantibodies induce anemia in a mouse model through multivalency-dependent hemagglutination but not through complement activation. Blood 2007; 109: 5355-62.
38. Ludwinski MW, Sun J, Hilliard B, Gong S, Xue F, Carmody RJ, et al. Critical roles of Bim in T cell activation and T cell-mediated autoimmune inflammation in mice. J Clin Invest 2009; 119: 1706-13.
39. + cells. J Exp Med 2008; 205: 565-74.
40. Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 18: 862-76.
41. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL,. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275: 36803-10.